This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Piper Sandler Remains a Buy on ICU Medical (ICUI)

Tipranks - Tipranks - Thu Jun 11, 6:52AM CDT

Piper Sandler analyst Jason Bednar maintained a Buy rating on ICU Medical today and set a price target of $163.00.

Introducing TipRanks MCP for Agents

According to TipRanks, Bednar is an analyst with an average return of -4.7% and a 40.85% success rate. Bednar covers the Healthcare sector, focusing on stocks such as ICU Medical, Merit Medical Systems, and Henry Schein.

In a report released on May 27, Needham also upgraded the stock to a Buy with a $165.00 price target.

See today’s best-performing stocks on TipRanks >>

Based on ICU Medical’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $530.37 million and a net profit of $30.13 million. In comparison, last year the company earned a revenue of $604.7 million and had a GAAP net loss of $15.48 million

Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ICUI in relation to earlier this year. Last month, Virginia Ruth Sanzone, the VP & GC of ICUI sold 2,447.00 shares for a total of $303,623.76.

Read More on ICUI:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).